These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20354203)

  • 1. Alterations in glycosylation as biomarkers for cancer detection.
    Reis CA; Osorio H; Silva L; Gomes C; David L
    J Clin Pathol; 2010 Apr; 63(4):322-9. PubMed ID: 20354203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of altered glycosylation of glycoproteins in cancer.
    Orntoft TF; Vestergaard EM
    Electrophoresis; 1999 Feb; 20(2):362-71. PubMed ID: 10197444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.
    Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):981-6. PubMed ID: 12923370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precancerous lesions and biologic markers in esophageal cancer.
    Mufti SI; Zirvi KA; Garewal HS
    Cancer Detect Prev; 1991; 15(4):291-301. PubMed ID: 1794136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of neoplastic cells in the lymphocytic infiltrate associated with thin melanomas.
    Salvio AG; Ribeiro DA; Marques ME
    Histopathology; 2007 Jun; 50(7):942-4. PubMed ID: 17543085
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
    Satomaa T; Heiskanen A; Leonardsson I; Angström J; Olonen A; Blomqvist M; Salovuori N; Haglund C; Teneberg S; Natunen J; Carpén O; Saarinen J
    Cancer Res; 2009 Jul; 69(14):5811-9. PubMed ID: 19584298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation characteristics of colorectal cancer.
    Holst S; Wuhrer M; Rombouts Y
    Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
    Berriel E; Hill M; Barcia JJ; Ubillos L; Gonzalez M; Detjen G; Rondan M; Navarrete H; Osinaga E
    Oncol Rep; 2005 Jul; 14(1):219-27. PubMed ID: 15944793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
    Zhao J; Qiu W; Simeone DM; Lubman DM
    J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
    Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
    Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
    Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
    J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
    van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
    Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
    Kumar SR; Sauter ER; Quinn TP; Deutscher SL
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glycomics approach to the discovery of potential cancer biomarkers.
    An HJ; Lebrilla CB
    Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives.
    Hakomori S
    Cancer Res; 1985 Jun; 45(6):2405-14. PubMed ID: 3886132
    [No Abstract]   [Full Text] [Related]  

  • 19. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.
    Narimatsu H; Iwasaki H; Nakayama F; Ikehara Y; Kudo T; Nishihara S; Sugano K; Okura H; Fujita S; Hirohashi S
    Cancer Res; 1998 Feb; 58(3):512-8. PubMed ID: 9458099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.